Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis

Published:2020-05-08 Issue:11 Volume:39 Page:3261-3276
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Kaveh Sara,Hosseinifard Hossein,Ghadimi Nashmil,Vojdanian Mahdi,Aryankhesal Aidin

Funder

Iran University of Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-020-04948-1.pdf

Reference44 articles.

1. Papapoulos S, Lippuner K, Roux C, Lin CJ, Kendler DL, Lewiecki EM, Brandi ML, Czerwinski E, Franek E, Lakatos P, Mautalen C, Minisola S, Reginster JY, Jensen S, Daizadeh NS, Wang A, Gavin M, Libanati C, Wagman RB, Bone HG (2015) The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM extension study. Osteoporos Int 26(12):2773–2783. https://doi.org/10.1007/s00198-015-3234-7

2. Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377(9773):1276–1287. https://doi.org/10.1016/s0140-6736(10)62349-5

3. Kling JM, Clarke BL, Sandhu NP (2014) Osteoporosis prevention, screening, and treatment: a review. J Women's Health (Larchmt) 23(7):563–572. https://doi.org/10.1089/jwh.2013.4611

4. Amelio P, Isaia GC (2015) Male osteoporosis in the elderly. Int J Endocrinol 2015:8. https://doi.org/10.1155/2015/907689

5. Bello MO, Garla VV (2019) Osteoporosis in males. In: StatPearls [internet]. StatPearls Publishing

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of romosozumab: a meta-analysis of placebo-controlled trials;Journal of Bone and Mineral Metabolism;2024-07-08

2. Anti-sclerostin antibody – A potential therapeutic target for periodontal bone regeneration;Journal of Oral Research and Review;2024-07

3. Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study;The Journal of Clinical Endocrinology & Metabolism;2024-03-14

4. Τhe story of sclerostin inhibition: the past, the present, and the future;Hormones;2024-01-03

5. Protocol for preliminary, multicenteric validation of “PoCOsteo device”: A point of care tool for proteomic and genomic study of osteoporosis;Biology Methods and Protocols;2024-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3